Human kinases and polynucleotides encoding the same

• US 6,797,510 B1
• Filed: 05/20/2002
• Issued: 09/28/2004
• Est. Priority Date: 05/24/2001
• Status: Expired due to Term

• Current Assignee: Lexicon Pharmaceuticals, Inc. (The Invus Group LLC)
• Original Assignee: Lexicon Genetics, Incorporated
• Inventors: Scoville, John, Walke, D. Wade, Friddle, Carl Johan
• Primary Examiner(s): Monshipouri, Maryam
• Application Number:
  US10/196,927
• Time in Patent Office: 862 Days
• Field of Search: 435/252.3, 435/320.1, 435/6, 435/325, 435/194, 536/23.2
• US Class Current: 435/252.3
• CPC Class Codes: C07H 21/04 with deoxyribosyl as saccharide radical
• CPC Class Codes: C12N 9/1205 Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1. An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:

3.

2. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO:

4.

3. A recombinant expression vector comprising a nucleic acid molecule encoding the amino acid sequence shown in SEQ ID NO:

4.

4. The recombinant expression vector of claims 3, wherein said nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO:

3.

5. A host cell comprising the recombinant expression vector of claim 3.